ArticleAnatomy & cell biology2026
Acellular lung matrix scaffold coated by fibronectin enhances hepatic differentiation of adipose-derived mesenchymal stem cells.
Article in Anatomy & cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
End-stage liver disease is a multifactorial disorder and leading cause of death. The development of effective tissue models has been a focus of research for treating liver disease. This study investigated the use of acellular lung matrix (ALM) and fibronectin (FN) to culture adipose-derived mesenchymal stem cells (ADMSCs) and promote their differentiation into hepatic-like cells. In this experimental study, sodium deoxycholate and NaCl were used to decellularize the lungs, and scaffolds were characterized by histology, scanning electron microscopy, and DNA quantification. ADMSCs were differentiated into hepatocyte-like cells using a two-step protocol under three conditions: in two-dimensional culture, on ALM scaffolds, and on FN-coated ALM scaffolds. Hepatic differentiation was confirmed by RT-PCR for specific genes (alpha-fetoprotein [AFP], albumin [ALB], cytokeratin-18 [CK-18]), ALB and urea levels were measured using specific commercial kits. The main extracellular matrix components (collagen and glycosaminoglycans) were preserved, and residual DNA was minimal (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.